Cargando…
906. Impact of Accelerate Rapid Diagnostic Technology on Time to Optimal Antimicrobial Therapy in Gram Negative Bloodstream Infection
BACKGROUND: Previous studies at our institution evaluating rapid diagnostic testing (RDT) for blood culture identification (BCID) did not show significant differences in time to optimal antimicrobial therapy for Gram negative bloodstream infections (GNBSI). Recent studies of Accelerate Pheno® system...
Autores principales: | Jung, Hye Lim, Jozefczyk, Caroline, Faulkner-Fennell, Carmen M, Shirley, Rhett, Schrank, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752526/ http://dx.doi.org/10.1093/ofid/ofac492.751 |
Ejemplares similares
-
141. Use of Rapid Diagnostic Testing in Gram-negative Bloodstream Infections with and without Antimicrobial Stewardship
por: Claeys, Kimberly C, et al.
Publicado: (2019) -
1986. Rapid Identification and Antimicrobial Susceptibility Testing Utilizing the Accelerate Pheno™ System for Gram-Negative Bloodstream Infections and Its Potential Clinical Impact
por: Schneider, Jack, et al.
Publicado: (2018) -
Clinical Impact of Rapid Identification (ID) and Phenotypic Antimicrobial Susceptibility Testing (AST) by Accelerate Pheno™ System (AXDX) for Gram-negative (GNB) Bloodstream Infections
por: Matic, Nancy, et al.
Publicado: (2017) -
Evaluation of a new Rapid Antimicrobial Susceptibility system for Gram-negative and Gram-positive bloodstream infections: speed and accuracy of Alfred 60AST
por: Anton-Vazquez, Vanesa, et al.
Publicado: (2019) -
Gram-Negative Bloodstream Infection: Implications of Antimicrobial Resistance on Clinical Outcomes and Therapy
por: Al-Hasan, Majdi N.
Publicado: (2020)